Literature DB >> 2182663

Treatment of spermagglutination with proteolytic enzymes. II. Sperm function after enzymatic disagglutination.

H A Pattinson1, D Mortimer, P J Taylor.   

Abstract

Antibody-mediated spermagglutination is responsible for infertility in some couples and fertilization in vitro can also be impaired by these antibodies. Having previously demonstrated the possibility of enzymatic disagglutination in such situations, the functional potential of disagglutinated spermatozoa has now been assessed. Chymotrypsin (500 U/ml) and papain (50 U/ml) resulted in impairment of oocyte penetration in the zona-free hamster egg penetration test. Trypsin (500 U/ml), while having no effect on egg penetration of normal spermatozoa, significantly improved oocyte penetration of spermatozoa which had been previously incubated with spermagglutinating antibody-positive sera. Sperm-mucus interaction was not improved, however, by trypsin treatment of agglutinated spermatozoa. This technique may be of value in conjunction with in-vitro fertilization in situations where spermagglutination exists, and also possibly with intra-uterine insemination if improved fertilizing ability can be confirmed in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182663     DOI: 10.1093/oxfordjournals.humrep.a137064

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

1.  Effect of limited proteolysis with alpha-chymotrypsin on semen with an abnormal sperm penetration assay and possible application for in vitro fertilization or intrauterine insemination.

Authors:  K L Honea; V L Houserman; D C Merryman; D A Free; S E Stringfellow
Journal:  J Assist Reprod Genet       Date:  1993-05       Impact factor: 3.412

Review 2.  Antisperm antibodies and conception.

Authors:  L W Chamley; G N Clarke
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

Review 3.  Sex difference in anti-sperm antibodies.

Authors:  Hiroaki Shibahara; Yuekun Chen; Haruka Honda; Yu Wakimoto; Atsushi Fukui; Akiko Hasegawa
Journal:  Reprod Med Biol       Date:  2022-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.